BioSpace News Archive

Biotech Bay

Summit Therapeutics Announces Commencement of $100 Million Rights Offering

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it has commenced its previously-announced rights offering of up to $100 million of the Company’s common stock.

July 18, 2022
·
5 min read
Business

Codexis Announces CEO Transition Effective August 9, 2022

Codexis, Inc. announced that its Board of Directors appointed Dr. Stephen Dilly, former CEO of Sierra Oncology, Inc. and current Codexis Board member, as the company’s President and CEO, effective August 9, 2022.

July 18, 2022
·
5 min read
Business

Emergent BioSolutions to Release Second Quarter 2022 Financial Results and Conduct Conference Call on August 1, 2022

Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, August 1, 2022, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2022, recent business developments, revenue guidance for the third quarter of 2022, and financial outlook for full year 2022.

July 18, 2022
·
1 min read
Business

QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a leading in vitro diagnostics company, today announced it will report financial results for its second quarter 2022 ended July 3, 2022, after the market close on Thursday, August 4, 2022.

July 18, 2022
·
1 min read
Business

PacBio to Report Second Quarter 2022 Financial Results on August 3, 2022

PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2022 financial results on Wednesday, August 3, 2022, at 5:00 pm Eastern Time.

July 18, 2022
·
1 min read
Business

Invitae Announces Leadership Transition

Invitae (NYSE: NVTA), a leading medical genetics company, today announced executive leadership and Board changes to help ensure the company realizes the full potential of its industry-leading genetics testing platform and delivers tangible and sustainable value for stockholders.

July 18, 2022
·
8 min read
Business

Vertex to Announce Second Quarter 2022 Financial Results on August 4

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2022 financial results on Thursday, August 4, 2022 after the financial markets close.

July 18, 2022
·
2 min read
Biotech Bay

Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow and Realize Full Potential of Industry-Leading Genetics Testing Platform

Invitae (NYSE: NVTA), a leading medical genetics company, today announced a comprehensive plan to realize the full potential of its industry-leading genetics platform.

July 18, 2022
·
13 min read
Business

Globus Medical Schedules 2022 Second Quarter Earnings Release and Conference Call

Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2022 after the market close on Thursday, August 4, 2022.

July 18, 2022
·
3 min read
Biotech Bay

Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - July 18, 2022

Myovant Sciences announced that it approved equity awards for 9 new employees with a grant date of July 15, 2022 pursuant to Myovant’s 2020 Inducement Plan.

July 18, 2022
·
2 min read